Company / Free Cash Flow per Share
Haemonetics Free Cash Flow per Share History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$2.82
FY2024
5-year range
$1.48 / $2.82
FY2020-FY2024
Trend
+1.0%
vs FY2023
Sector context
#58 of 142
Health Care
What the data says
At $2.82, Haemonetics's free cash flow per share ranks #58 of 142 in the Health Care sector. Free Cash Flow per Share has increased for 4 consecutive years, from $1.40 in FY2020 to $2.82 in FY2024.
Based on SEC 10-K filings.
2.82 in FY2024 with a 5-year CAGR of +6.0%.
Improved from $1.59 to $2.82 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +24.2%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
#58 of 142 in Health CareTop 41% of 142This company $2.82 Sector average $5.16
▼
-45.3% below sector average
Key checks
Key Insights
- Haemonetics's free cash flow per share has grown for 4 consecutive years.
- In FY2024, free cash flow per share increased 1.0% year-over-year.
- Ranks #58 out of 142 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score 0.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $2.82 | +1.0% |
| FY2023 | $2.79 | +75.8% |
| FY2022 | $1.59 | +7.7% |
| FY2021 | $1.48 | +5.4% |
| FY2020 | $1.40 | -33.8% |
| FY2019 | $2.11 | +173.8% |
| FY2018 | $0.77 | -73.0% |
| FY2017 | $2.86 | +76.6% |
| FY2016 | $1.62 | +332.7% |
As of FY2024 · SEC 10-K · Updated Mar 28, 2026